These results suggest that miRNA, WTAP, and CDK2 are jointly involved in the progression of various tumors, which is consistent with our experimental results showing that miR‐501‐3p enhances the progression of RCC via the miR‐501‐3p/WTAP/CDK2 axis. This evidence concerns the gene CDK2 and renal cell carcinoma.